- Home
- ATLO vs IKT Comparison
ATLO vs IKT Comparison
Compare ATLO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- IKT
- Stock Information
- Founded
- ATLO 1903
- IKT 2008
- Country
- ATLO United States
- IKT United States
- Employees
- ATLO N/A
- IKT N/A
- Industry
- ATLO Major Banks
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- IKT Health Care
- Exchange
- ATLO Nasdaq
- IKT Nasdaq
- Market Cap
- ATLO 158.4M
- IKT 140.5M
- IPO Year
- ATLO N/A
- IKT 2020
- Fundamental
- Price
- ATLO $18.41
- IKT $1.77
- Analyst Decision
- ATLO
- IKT Buy
- Analyst Count
- ATLO 0
- IKT 2
- Target Price
- ATLO N/A
- IKT $8.00
- AVG Volume (30 Days)
- ATLO 16.7K
- IKT 497.3K
- Earning Date
- ATLO 08-08-2025
- IKT 08-13-2025
- Dividend Yield
- ATLO 4.34%
- IKT N/A
- EPS Growth
- ATLO 43.60
- IKT N/A
- EPS
- ATLO 1.53
- IKT N/A
- Revenue
- ATLO $57,731,000.00
- IKT N/A
- Revenue This Year
- ATLO N/A
- IKT N/A
- Revenue Next Year
- ATLO N/A
- IKT N/A
- P/E Ratio
- ATLO $12.07
- IKT N/A
- Revenue Growth
- ATLO 12.59
- IKT N/A
- 52 Week Low
- ATLO $15.69
- IKT $1.12
- 52 Week High
- ATLO $22.03
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- ATLO 56.01
- IKT 43.91
- Support Level
- ATLO $17.75
- IKT $1.76
- Resistance Level
- ATLO $18.69
- IKT $2.05
- Average True Range (ATR)
- ATLO 0.29
- IKT 0.12
- MACD
- ATLO 0.00
- IKT -0.00
- Stochastic Oscillator
- ATLO 70.21
- IKT 5.88
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.